Image Place holder

Michael Montejo, MD


Specialty: Radiation Oncology
Program: Radiation Oncology

Call 1-888-MOFFITT
(1-888-663-3488)

or call 1-888-MOFFITT
(1-888-663-3488)

Overview

Dr. Montejo joined the Moffitt Radiation Oncology Faculty in 2013 and currently serves as the departmental section head for the gynecologic radiation oncology service and radiation oncology service at Moffitt International Plaza satellite. His clinical interests include management of lymphoma, female gynecologic and breast malignancies including application of brachytherapy and modern highly conformal image-guided external beam radiotherapy. His research interests include brachytherapy and adaptation of highly conformal image-guided external body radiosurgery techniques to gynecologic and breast malignancy applications.

Education & Training

Board Certification:

  • Radiation Oncology

Fellowship:

    Residency:

    • University of Utah Medical Center, Huntsman Cancer Hospital - Radiation Oncology

    Medical School:

    • University of South Florida College of Medicine - MD
    Participating Trials

    CLINICAL TRIAL 18596
    A Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy
    Condition: Breast
    Intervention: Not Applicable
    Open

    CLINICAL TRIAL 18395
    Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin's Lymphoma
    Condition: Malignant Hematology
    Intervention: G100; Pembrolizumab (Keytruda)
    Open

    CLINICAL TRIAL 18356
    A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients who have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
    Condition: Breast
    Intervention:
    Open

    CLINICAL TRIAL 18386
    A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
    Condition: Breast
    Intervention: Not Applicable
    Open

    CLINICAL TRIAL 18527
    Non-Comparative, Open-Label, Multiple Cohort, Phase 1/2 Study of Nivolumab Monotherpay and Nivolumab Combination Therapy in Subjects with Virus-Positive and Virus-Negative Solid Tumors
    Condition: Multiple
    Intervention: BMS-936558 (Nivolumab); Ipilimumab; Nivolumab; Not Applicable; Yervoy (Ipilimumab)
    Open

    CLINICAL TRIAL 18527
    Non-Comparative, Open-Label, Multiple Cohort, Phase 1/2 Study of Nivolumab Monotherpay and Nivolumab Combination Therapy in Subjects with Virus-Positive and Virus-Negative Solid Tumors
    Condition: Multiple
    Intervention: BMS-936558 (Nivolumab); Ipilimumab; Nivolumab; Not Applicable; Yervoy (Ipilimumab)
    Open

    If you believe you are eligible for one of these trials or studies, please call
    1-888-MOFFITT (1-888-663-3488).

    Publications

    • Mellon EA, Orman A, Joya LE, Montejo ME, Laronga C, Hoover SJ, Lee MC, Khakpour N, Kubal PF, Diaz R. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy. Brachytherapy. 2017 Jul;16(1):174-180. Pubmedid: 27816540.
    • Montejo ME, Shrieve DC, Bentz BG, Hunt JP, Buchman LO, Agarwal N, Hitchcock YJ. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2011 Dec;81(5):e845-e852. Pubmedid: 21167654.
    • Montejo M, Werner TL, Gaffney D. Current challenges in clinical management of endometrial cancer. Adv Drug Deliv Rev. 2009 Aug;61(10):883-889. Pubmedid: 19422864.
    • Torres-Roca JF, Cantor AB, Shukla S, Montejo ME, Friedland J, Seigne JD, Heysek R, Heysek, Randy, Pow-Sang J. Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience. Urol Oncol. 2006 Sep;24(5):384-390. Pubmedid: 16962486.